The NIH has awarded a $3 million research grant to CND Life Sciences to initiate a 3-year multicenter study to evaluate the validity of a skin punch biopsy test to determine risk for Parkinson’s ...
Shares of Praxis Precision Medicines more than tripled Thursday, peaking at $200 apiece, after the company disclosed positive ...
Shares of Praxis Precision Medicine shot 251% higher in a little over a week during the month of October. Praxis Precision ...
Stock futures edged higher Thursday morning as investors digested upbeat earnings from semiconductor leader Taiwan ...
Early investigators began testing how focused ultrasound could treat neurological disorders, pain and even cancer. open image ...
Praxis Precision Medicines said on Thursday its experimental drug for movement disorder helped improve daily functioning in patients in two late-stage trials, sending its shares surging more than ...
Investor's Business Daily on MSN
The 'Groundbreaking' Results That Sent Praxis Precision Medicines Up 184%
Shares of Praxis Precision Medicines skyrocketed 184% Thursday on "groundbreaking" test results for an essential tremor ...
Praxis Precision Medicines said patients with a condition that causes uncontrollable shaking saw improvement using its ...
A series of earthquakes have been recorded in the Canary Islands in recent days including a tremor measuring 3.4 on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback